This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 1993-1995.
Location History:
- Ann Arbor, MI (US) (1993)
- Burlington, MA (US) (1995)
Company Filing History:
Years Active: 1993-1995
Title: Innovations of Shu-Ching Ma
Introduction
Shu-Ching Ma is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of electrochemical sensors, particularly in the detection of heparin. With a total of 2 patents, her work has implications for medical diagnostics and monitoring.
Latest Patents
One of her latest patents is the Heparin-selective polymeric membrane electrode. This invention involves an anion exchange membrane designed for ionic macromolecules, specifically heparin. The membrane is formed from a polymeric matrix material and an anion exchange material suitable for heparin detection. It can be utilized in an electrochemical sensor arrangement to directly measure the concentration of heparin ions in blood or blood fluid. The potentiometric response to heparin has been observed with membranes comprising 30-70 wt. % polymeric matrix material, such as polyvinyl chloride, along with 0.1-12 wt. % quaternary ammonium salt, such as tridodecyl methyl ammonium chloride, and 30-70 wt. % of a plasticizer, such as dioctyl sebacate. Additionally, a solid-state sensor employs tridodecyl methyl ammonium chloride (TDMAC) dissolved in a polymeric compound, such as silicone rubber, to form a membrane that is responsive to heparin concentration.
Career Highlights
Shu-Ching Ma is affiliated with the University of Michigan, where she continues her research and development in innovative technologies. Her work has garnered attention for its potential applications in healthcare and diagnostics.
Collaborations
Some of her notable coworkers include Victor C Yang and Mark E Meyerhoff, who have collaborated with her on various projects.
Conclusion
Shu-Ching Ma's contributions to the field of electrochemical sensors highlight her innovative spirit and dedication to advancing medical technology. Her patents reflect her commitment to improving healthcare through scientific research and development.